 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | TropMed Pharma Consulting |
| Street 1: | 10 Brampton Chase |
| Street 2: | |
| City: | Lower Shiplake |
| Province: | Oxfordshire |
| Post Code: | RG9 3BX |
| Country: | United Kingdom of Great Britain and Northern Ireland |
| Phone: | + 44 (118) 940 3349 |
| Email: | info@tropmedpharma.com |
| Web Site: | http://www.tropmedpharma.com |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | Private sector |
| Organization Type - Primary: | Private Sector |
| Organization Type - Secondary: | Company |
| Is your organization legally registered in your country: | Yes |
| Organization Reach: | International |
| Organization Description: | |
| Small consultancy specialising in working with companies and organisations active in communicable diseases that disproportionately affect the developing world, especially in the field of strategy and the transition from late stage product development to full commercialisation. We are involved with the Global Fund Market Dynamics Advisory Group and its work of TB drugs and diagnostic market dynamics. | |
| Total number of staff in your organization: | 1 - 5 |
| Number of full-time staff who are directly involved with TB: | 1 - 5 |
| Number of part-time staff who are directly involved with TB: | 0 |
| Number of volunteers who are directly involved with TB: | 0 |
| What is your organization's annual budget (USD) dedicated to TB? | Unable to disclose amount |
| How did you hear about the Stop TB Partnership: | Other partners |
| Why do you wish join the Stop TB Partnership: | Information on developments within the TB world |
| Are you a member of a Stop TB national partnership: | No |
| Are you in contact with your national TB programme: | No |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| N/A | |
Geographical Reach | |
| Which country is your headquarters located in: | United Kingdom of Great Britain and Northern Ireland |
| Which WHO region is the main focus of your work: | African |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
United Kingdom of Great Britain and Northern Ireland |
Specializations | |
|
Research and Development Technical Assistance |
Specializations in Countries | |
| Research and Development | United Kingdom of Great Britain and Northern Ireland |
| Technical Assistance | United Kingdom of Great Britain and Northern Ireland |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
DOTS Expansion and Enhancement: Works within the Global Fund's Market Dynamics Advisory Group to improve access to high quality diagnostic testing and treatment. Drug-Resistant TB: Works within the Global Fund's Market Dynamics Advisory Group to improve access to high quality diagnostic testing and treatment. TB-HIV: Works within the Global Fund's Market Dynamics Advisory Group to improve access to high quality diagnostic testing and treatment. New Diagnostics: Works within the Global Fund's Market Dynamics Advisory Group to improve access to high quality diagnostic testing and treatment. New TB Drugs: Works within the Global Fund's Market Dynamics Advisory Group to improve access to high quality diagnostic testing and treatment. |
|
Declaration | |
| Declaration of interests: GlaxoSmithKline (shareholder & pensioner) Consultancy contracts in the past with UNITAID & Global Fund. | |
| Application date: | November 26, 2012 |
| Last updated: | November 26, 2012 |